A group of renowned and highly specialized scientists form the core of Profil. Divided into several teams, they specialize in each of our focus areas of diabetes- and obesity-related medication and technology. Our scientists are dedicated to improving the diagnosis, treatment and quality of life for people suffering from diabetes and obesity.
Furthermore, our R&D and Science and Innovation departments ensure that our expertise on clinical research and healthcare innovation develop continuously, thereby contributing to the most optimal outcome for our clients.
Read about our leading scientists and their teams.
Director Clinical Pharmacology
Grit is a board certified medical specialist in clinical pharmacology and has been with Profil for several years and among other responsibilities she is running the specialization program in clinical pharmacology for medical doctors.
Sabine has worked in diabetes for more than 20 years with a background in both academia and 9 years pharmaceutical industry. She has been Principal Investigator for clamp trials and the artifical pancreas trials (AP@Home). Currently she is also building a network with diabetologists and GP practices.
Scientific Study AdvisorJorge is a medical doctor with experience in academic research. He joined Profil in 2015 and contributes to the project development team with his medical and scientific knowledge.
Director Technical Development
Carsten is a physicist in the field of nano-structured surfaces on condensed matter and has long-term experience in hardware and software development of medical devices. At Profil he is the Director of Technical Development and manager of the AP@home EU project.
Scientific Study AdvisorSusanne started her career as scientist in the field of diabetes more than 10 years ago with a PhD program at the German Diabetes Center. She has a special focus on type 1 diabetes and its treatment.
Hans has an international reputation for his scientific contributions in the fields of treatment of type 1 and 2 diabetes as well as in the development of an artificial pancreas. He has authored or co-authored in excess of 200 original articles in peer reviewed international journals.
Tim has over 25 years of experience in clinical research and care in diabetes and obesity. He has published >120 scientific papers and reviews focussing on the pharmacology of insulin and anti-diabetic drugs. He is on the Editorial Board for Diabetes, Obesity and Metabolism.
Research Physician / Scientific Study Advisor
Theresa started at Profil as a research physician in 2015 and joined the Project Development team shortly after. She is involved in designing and conducting clinical trials using both her medical as well as clinical trials background.
Scientific Study Advisor
Ulrike has many years of experience in the clinical setting at Profil and now uses this expertise in the project development team to drive project excellence.
Chief Executive Officer
Christoph has >20 years of diabetes research experience in the development of drugs, and devices. He has consulted in the clinical development plans of several new therapeutic entities. His particular expertise lies in the field of incretin hormones.
Scientific Study AdvisorOliver has several years of clinical experience and combines this with his scientific accumen to optimize the study design for novel antidiabetic drug developments.
Nutritional Science SpecialistDaniela has more than 10 years of experience in the field of diabetes and obesity, starting her academic education with her PhD programme at the German Diabetes Center in Düsseldorf. In the project development team at Profil she focusses on studies treating obesity as well as food / food supplement studies.
Chief Executive Officer - Profil Mainz
Leona has profound expertise in the field of obesity, diabetes, and metabolism. She has a strong research background in academia and industry with particular know-how in basic science of molecular endocrinology and energy metabolism.
Director Science & InnovationFreimut is a biochemist with longstanding scientific activities in the fields of experimental hepatology and molecular medicine. His focus is the advancement of Profil's innovation project portfolio.
Executive Director Project DevelopmentEric is a clinical research specialist and is well-known for his scientific contributions to international meetings and diabetes journals. His main expertise lies in the field of diabetes technology and alternative route administrations of insulin.